Autres langues Tianjin Lisheng Pharmaceutical Co.,Ltd.

Actions

002393

CNE100000NJ9

Cours en clôture Shenzhen S.E. Autres places de cotation 00:00:00 30/04/2024			Varia. 5j.	Varia. 1 janv.
25,45 ^CNY	+0,39 %		+4,35 %	-2,49 %

24/04	Tianjin Lisheng Pharmaceutical Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI
22/03	Les bénéfices de Tianjin Lisheng Pharmaceutical pour 2023 augmentent grâce aux gains provenant des cessions d'actifs ; les actions bondissent de 4 %.	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Tianjin Lisheng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04
Tianjin Lisheng Pharmaceutical Co.,Ltd. Proposes Cash Dividend for the Year 2023	22/03
Tianjin Lisheng Pharmaceutical's 2023 Profit Surges on Gains from Asset Disposals; Shares Jump 4%	22/03
Tianjin Lisheng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	26/02
Lisheng Pharmaceutical Buys 65% Stake in Qingchun Kangyuan Pharmaceutical for 137 Million Yuan; Shares Up 3%	02/01
Tianjin Arm Lisheng Pharmaceutical To Buy Chinese Medicine Firm Jiangxi Qingchun Kangyuan	14/12
Tianjin Lisheng Pharmaceutical Co.,Ltd. agreed to acquire 65% stake in Jiangxi Qingchun Kangyuan Pharmaceutical Co., Ltd. from Jiangxi Qingchun Kangyuan Group Co., Ltd. and Jiangxi Qingchun Kangyuan Chinese Medicine Co., Ltd. for approximately CNY 140 million.	14/12
Tianjin Lisheng Pharma Setting Up Venture Capital Fund	12/12
Lisheng Pharmaceutical and Lisheng Investment Enter into the Partnership Agreement with Bozheng Capital, Tianjin Jinjia and Tianjin Handeway	11/12
Tianjin Development to Vote Dec. 5 on Lisheng Pharma's Sale of Tianjin Pharmaceutical Finance Stake	10/11
Tianjin Lisheng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	29/10/23
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited agreed to acquire additional 15% stake in Tianjin Pharmaceutical Group Finance Co., Ltd from Tianjin Lisheng Pharmaceutical Co.,Ltd. for CNY 87.8 million.	11/09/23
Lisheng Pharmaceutical's H1 Attributable Profit Jumps	25/08/23
Tianjin Lisheng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23
Lisheng Pharmaceutical Subscribes for 20 Million Yuan Wealth Management Product	02/08/23
Lisheng Pharma to Receive 247.9 Million Yuan for Relocation	26/07/23
Lisheng Pharmaceutical Eyes 247.9 Million Yuan from Potential Land Resumption Deal	26/07/23
Tianjin Lisheng Pharmaceutical Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date Is 30 June 2023	20/06/23
Tianjin Lisheng Pharma Gets Nod For Febuxostat Active Pharma Ingredient in China	15/06/23
Lisheng Pharma Unit's Drug Passes Regulatory Evaluation	15/05/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Tianjin Lisheng Pharmaceutical Co.,Ltd.

Actions

002393

CNE100000NJ9

Autres langues

Filtres